Associate Professor, Surgery, Perelman School of Medicine
General Surgery
Dr. Julia C. Tchou, MD
|
|
Give Review
Julia Tchou works in the field of General Surgery. She went to Stony Brook University School of Medicine. She has 5 awards "Philadelphia Magazine", "America's Top Doctors", "America's Top Doctors for Cancer", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Julia Tchou is a published physician. She published 51 publications, including: 'Function of the zinc finger in Escherichia coli Fpg protein.' She accepts Medicare.
Publications
- Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.
- Clinical Diagnosis and Management of Breast Cancer.
- Identification of breast Cancer margins using intraoperative near-infrared imaging.
- Satb1 Overexpression Drives Tumor-Promoting Activities in Cancer-Associated Dendritic Cells.
- Resident and Fellow Participation in Breast Surgery: An American College of Surgeons NSQIP Clinical Outcomes Analysis.
- A Cost-Utility Analysis Comparing the Sartorius Versus the Rectus Femoris Flap in the Treatment of the Infected Vascular Groin Graft Wound.
- A Cost-Utility Analysis of the Use of Preoperative Computed Tomographic-Angiography in Abdomen-Based Perforator Flap Breast Reconstruction.
- Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation.
- Mesothelin expression is associated with poor outcomes in breast Cancer.
- Transforming Growth Factor β-Mediated Suppression of Antitumor T Cells Requires FoxP1 Transcription Factor Expression.
- Association Between Lymphedema Self-Care Adherence and Lymphedema Outcomes Among Women with Breast Cancer-Related Lymphedema.
- Mastectomy with or without immediate implant reconstruction has similar 30-day perioperative outcomes.
- Abstract 36: Risk Assessment of Immediate Breast Reconstruction Relative to Mastectomy Alone: Analysis of 30-day Complications Using the ACS-NSQIP.
- Fibroblast activation protein, a potential diagnostic and therapeutic target for Cancer-reply.
- Characterizing the metabolic heterogeneity in human breast Cancer xenografts by 3D high resolution fluorescence imaging.
- Identification of a long non-coding RNA-associated RNP complex regulating metastasis at the translational step.
- Prescription and adherence to lymphedema self-care modalities among women with breast Cancer-related lymphedema.
- Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast Cancer.
- Response to HER-2 Pulsed DC1 Vaccines is Predicted by Both HER-2 and Estrogen Receptor Expression in DCIS.
- Redox imaging of human breast Cancer core biopsies: a preliminary investigation.
- Diagnostic and prognostic application of positron emission tomography in Breast imaging: emerging uses and the role of PET in monitoring treatment response.
- The 2011-2016 Transdisciplinary Research on Energetics and Cancer (TREC) Initiative: Rationale and Design.
- Optical malignancy parameters for monitoring progression of breast Cancer neoadjuvant chemotherapy.
- Breast reconstruction in bilateral prophylactic mastectomy patients: Factors that influence decision making.
- Imaging the redox States of human breast Cancer core biopsies.
- Challenges in the clinical utility of the serum test for HER2 ECD.
- Mesothelin, a novel immunotherapy target for triple negative breast Cancer.
- Biopsy findings after breast conservation therapy for early-stage invasive breast Cancer.
- Diffuse optical measurement of blood flow in Breast tumors.
- Optically measured microvascular blood flow contrast of malignant Breast tumors.
- Function of the zinc finger in Escherichia coli Fpg protein.
- Recognition and repair of 8-oxoguanine and formamidopyrimidine lesions in DNA.
- The catalytic mechanism of Fpg protein. Evidence for a Schiff base intermediate and amino terminus localization of the catalytic site.
- Repair of DNA containing the oxidatively-damaged base, 8-oxoguanine.
- Substrate specificity of Fpg protein. Recognition and cleavage of oxidatively damaged DNA.
- 8-oxoguanine (8-hydroxyguanine) DNA glycosylase and its substrate specificity.
- A repair system for 8-oxo-7,8-dihydrodeoxyguanine.
- A mammographic dilemma: calcification or haemosiderin as a cause of opacities? Validation of a new digital diagnostic tool.
- Barriers to rehabilitation following surgery for primary breast Cancer.
- Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort Analysis of 158 mutation carriers treated at a single ...
- Computer aided automatic detection of malignant lesions in diffuse optical mammography.
- Degree of tumor FDG uptake correlates with proliferation index in triple negative breast Cancer.
- Differentiation of benign and malignant Breast tumors by in-vivo three-dimensional parallel-plate diffuse optical tomography.
- Method of primary tumor detection as a risk factor for local and distant recurrence after breast-conservation treatment for early-stage breast Cancer.
- Mammographic appearance of recurrent breast Cancer after breast conservation therapy.
- Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative Breast carcinoma using quantitative fluorine-18 fluorodeoxygl...
- Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast Cancer in the United States.
- Acceptance of tamoxifen chemoprevention by physicians and women at risk.
- Available models for breast Cancer risk assessment: how accurate are they?
- GSTP1 CpG island DNA hypermethylation in hepatocellular Carcinomas.
Schools
State University of New York Health Science Center At Stony Brook
Johns Hopkins Med Institute
Lynnsage Brst CtrNrthwstrn Mem University Hospital
Procedures Preformed
- Biopsy of Breast
- Breast Reconstruction
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Excision of Breast Tumor
- View All
Conditions Treated
- Anal and Rectal Cancer
- Breast Cancer
- Breast Lump
- Carcinoma in Situ
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- Philadelphia Magazine
- America's Top Doctors
- America's Top Doctors for Cancer
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Johns Hopkins University -
Stony Brook University School of Medicine
Hospital
-
Hospital of the University of Pennsylvania
Drug Facts
| NPI NUMBER | 1508896648 | |
| NPPES Provider LastName | TCHOU | |
| NPPES Provider FirstName | JULIA | |
| NPPES Provider ZIPCode | 19104 | |
| NPPES Provider State | PA | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 42.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1508896648 |
| Last Name Of The Provider | TCHOU |
| First Name Of The Provider | JULIA |
| View All |
Similar Doctors
|
|
Dr. Raymond C. Talucci, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher A. Butts, DO |
|
|
Dr. Matthew E. Hardy, MD |
|
|
Dr. Seiji Yamaguchi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allison L. Tan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick E. McGovern, MD |
|
|
Dr. Kathreen P. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David I. Hindin, MD |
|
|
Dr. John Levin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Esther Tseng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David J. Kaczorowski, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arthur J. Barnaby Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Marshall Z. Schwartz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel R. Kelz, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Howard S. Caplan, MD
This Doctor is OpenDoctor Recommended.
|